MOUNTAIN VIEW, Calif. -- Scios Inc. and Baltimore-based Nova Pharmaceutical Corp. said they have agreed to merge.
In a news release today, the companies said holders of Nova Pharmaceutical common stock will exchange each of their shares for 0.39 share of Scios.
The combined company will be called Scios-Nova Inc., with headquarters in Mountain View. It will maintain a research facility in Baltimore.
The companies put the transaction value at $180 million.